AQB
AQB
NASDAQ · Biotechnology

Aquabounty Technologies

$0.82
+0.04 (+5.24%)
As of Feb 8, 2:34 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 557.3K 516.3K 473.8K
Net Income 76.7K 85.4K 67.5K
EPS
Profit Margin 13.8% 16.5% 14.2%
Rev Growth +2.4% +15.9% +18.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.31M 1.47M 1.37M
Total Equity 2.49M 2.28M 2.29M
D/E Ratio 0.52 0.64 0.60
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 122.1K 108.8K 88.6K
Free Cash Flow 55.8K 59.0K 42.6K